miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1

[1]  Xianjun Yu,et al.  Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling , 2018, Oncogene.

[2]  A. Tanoue,et al.  BIG1/Arfgef1 and Arf1 regulate the initiation of myelination by Schwann cells in mice , 2018, Science Advances.

[3]  E. Sturgis,et al.  Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer , 2017, JAMA otolaryngology-- head & neck surgery.

[4]  David F. Schneider,et al.  Back so soon? Is early recurrence of papillary thyroid cancer really just persistent disease? , 2018, Surgery.

[5]  L. Kwong,et al.  Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy , 2017, Cancer and Metastasis Reviews.

[6]  R. Vyzula,et al.  MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9 , 2017, Oncogenesis.

[7]  Fenghua Wang,et al.  Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression , 2017, Theranostics.

[8]  Kunpeng Liu,et al.  miR-215 promotes cell migration and invasion of gastric cancer by targeting Retinoblastoma tumor suppressor gene 1. , 2017, Pathology, research and practice.

[9]  J. Fuxe,et al.  Epithelial‐mesenchymal transition in cancer metastasis through the lymphatic system , 2017, Molecular oncology.

[10]  Xiaofeng Meng,et al.  miR-215 functions as an oncogene in high-grade glioma by regulating retinoblastoma 1 , 2017, Biotechnology Letters.

[11]  Y. Kanai,et al.  Cluster microRNAs miR‐194 and miR‐215 suppress the tumorigenicity of intestinal tumor organoids , 2017, Cancer science.

[12]  S. Khan,et al.  miRNA nanotherapeutics for cancer. , 2017, Drug discovery today.

[13]  J. Pan,et al.  miR-215 promotes cell migration and invasion of gastric cancer cell lines by targeting FOXO1. , 2017, Neoplasma.

[14]  Gregory J. Goodall,et al.  A network-biology perspective of microRNA function and dysfunction in cancer , 2016, Nature Reviews Genetics.

[15]  B. Wojtaś,et al.  Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants , 2016, International journal of endocrinology.

[16]  J. Moss,et al.  Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals , 2016, Proceedings of the National Academy of Sciences.

[17]  R. McLendon,et al.  MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. , 2016, Cancer cell.

[18]  M. Okada,et al.  MicroRNA‐27b suppresses tumor progression by regulating ARFGEF1 and focal adhesion signaling , 2015, Cancer science.

[19]  C. Sturgeon,et al.  Surgical Management of Lymph Node Compartments in Papillary Thyroid Cancer. , 2016, Surgical oncology clinics of North America.

[20]  M. Zeiger,et al.  MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review. , 2015, Thyroid : official journal of the American Thyroid Association.

[21]  Q. W. Li,et al.  MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer. , 2015, Genetics and molecular research : GMR.

[22]  Ming-Hsun Wu,et al.  Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer , 2015, Head & neck.

[23]  Yan Hou,et al.  miR-215 functions as a tumor suppressor and directly targets ZEB2 in human non-small cell lung cancer , 2015, Oncology letters.

[24]  H. Kim,et al.  miR-215 overexpression distinguishes ampullary carcinomas from pancreatic carcinomas. , 2015, Hepatobiliary & pancreatic diseases international : HBPD INT.

[25]  P. Qi,et al.  Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients , 2014, Medical Oncology.

[26]  Yibin Kang,et al.  MiR-215 modulates gastric cancer cell proliferation by targeting RB1. , 2014, Cancer letters.

[27]  Y. Wang,et al.  BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein regulates neurite development via PI3K–AKT and ERK signaling pathways , 2013, Neuroscience.

[28]  G. Yousef,et al.  miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma. , 2013, Carcinogenesis.

[29]  J. Moss,et al.  Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex , 2013, Proceedings of the National Academy of Sciences.

[30]  E. Kondo,et al.  Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway , 2012, British Journal of Cancer.

[31]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[32]  J. Moss,et al.  Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing , 2011, Proceedings of the National Academy of Sciences.

[33]  A. Evans,et al.  miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215 , 2011, British Journal of Cancer.

[34]  Matthew A. Titmus,et al.  Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells , 2010, Molecular Cancer.

[35]  Aimee L Jackson,et al.  Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. , 2008, Cancer research.

[36]  E. Izaurralde,et al.  Getting to the Root of miRNA-Mediated Gene Silencing , 2008, Cell.

[37]  Xinhua Zhao,et al.  Localization of large ADP-ribosylation factor-guanine nucleotide exchange factors to different Golgi compartments: evidence for distinct functions in protein traffic. , 2002, Molecular biology of the cell.

[38]  V. Ferrans,et al.  Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex. , 2000, Proceedings of the National Academy of Sciences of the United States of America.